Veledimex, formerly known as AD-1001, INXN-1001 and RG-115932 is a drug potentially for the treatment of melanoma and breast cancer References: Cai H, Sun L, Miao J, Krishman S, Lebel F, Barrett JA. Plasma Pharmacokinetics of Veledimex, a Small-Molecule Activator Ligand for a Proprietary Gene Therapy Promoter System, in Healthy Subjects. Clin Pharmacol Drug Dev. 2016 Jul 1. doi: 10.1002/cpdd.287. [Epub ahead of print] PubMed PMID: 27364771.

纯度：≥98%

CAS：1093130-72-3